Board of Directors

Entrepreneur-In-Residence, Third Rock Ventures
Since 2010, Bob Kamen has served as an entrepreneur-in-residence at Third Rock Ventures. Bob focuses on the formation and development of biologics companies that develop life-changing therapies for patients. Bob brings more than 30 years of leadership experience in the pharmaceutical and
Chief Executive Officer, Neon Therapeutics
Neon Therapeutics’ chief executive officer, Hugh O’Dowd, joined the company in 2016, bringing more than 20 years of expertise in pharmaceutical leadership and moving important oncology therapies from clinical development through commercialization. Hugh joined Neon Therapeutics from Novartis
Clinical Professor of Medicine, University of California San Francisco
Stephen Sherwin currently divides his time between advisory work in the life science industry and patient care and teaching in his specialty of medical oncology. He is a clinical professor of medicine at the University of California, San Francisco and a volunteer attending physician in
Chairman & CEO, Gamida Cell
Julian Adams is a renowned scientist known for his success developing high-impact therapies for cancer and HIV. Julian played a pivotal role in the development of multiple products to reach the market, including Viramune® (nevirapine) for HIV, and Velcade® (bortezomib), a proteasome inhibitor that
Former Novartis executive
Meryl Zausner has more than 35 years of experience developing and launching innovative business units in the pharmaceutical and consumer product industry. Previously, Meryl served as chief financial and administrative officer of Novartis Pharmaceuticals Inc.